• Follow
  • Follow
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise

Log in

Start free trial
G2 Intelligence
  • Reports
    • Lab Industry Advisor
      • Essentials Reports
      • Premium Reports
      • Elite Reports
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Articles
    • Lab Industry Advisor
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Webinars
  • Store
  • Reports
    • Lab Industry Advisor
      • Essentials Reports
      • Premium Reports
      • Elite Reports
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Articles
    • Lab Industry Advisor
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Webinars
  • Store
Reimbursement: ABN’s Failure to Include List Prices for Denied Lab Tests Is Not Consumer Fraud

Reimbursement: ABN’s Failure to Include List Prices for Denied Lab Tests Is Not Consumer Fraud

by Glenn S. Demby | May 15, 2023 | Essential, Labs in Court-nir, National Lab Reporter

Recent case shows why failing to disclose to individuals the lab test list prices they may need to pay doesn’t count as consumer fraud.

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
Thriving in a Difficult Economy: Patient-centric Strategies That Will Improve Your Bottom Line

Thriving in a Difficult Economy: Patient-centric Strategies That Will Improve Your Bottom Line

by G2 Intelligence Staff | May 15, 2023 | OLP, Webinars

Learn how your lab can effectively respond in these uncertain economic times to strengthen your competitive advantage and your bottom line.

How to Perform a Billing, Coding, & Reimbursement Process Compliance Audit

How to Perform a Billing, Coding, & Reimbursement Process Compliance Audit

by Diana Voorhees, MA, MLS(ASCP)SH, CLCP, CPCO | May 3, 2023 | Essential, Lab Compliance Advisor, Reimbursement-lca

Auditing in medical laboratories is critical for reviewing processes to identify erroneous outcomes, as well as areas for improvement.

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
Compliance Alert: Start Using New ABN Form on June 30

Compliance Alert: Start Using New ABN Form on June 30

by Glenn S. Demby | Apr 24, 2023 | News, Open Content

Labs must use the new Advance Beneficiary Notice of Noncoverage (ABN) form starting on June 30, 2023, when the old version expires.

Lab Institute Virtual Event: Dealing with a Difficult Economy

Lab Institute Virtual Event: Dealing with a Difficult Economy

by G2 Intelligence Staff | Apr 6, 2023 | News, OLP, Webinars

Our June virtual event will offer a variety of solutions and strategies for dealing with key issues labs face during times of economic strife.

« Older Entries
Next Entries »

Sign up for our free weekly Lab & Pathology Insider email newsletter

Log In

Join Now | Lost Password?
  • Follow
  • Follow
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
Copyright © 2025 G2Intelligence.com